How to Choose EEG / EMG Systems

A procurement guide for neurology departments, epilepsy units, PM&R clinics, and ASCs navigating a crowded and technically demanding market.

---

What this is and who buys it

Electroencephalographs (EEG) and electromyographs (EMG) are functional diagnostic platforms that capture bioelectric signals — the former from the brain's cortical surface via scalp electrodes, the latter from skeletal muscle and peripheral nerves via surface or needle electrodes. They are distinct technologies that share amplifier architecture, and many modern clinical platforms run both modalities through a single hardware box with software licensing determining what the system can do.

The buyer pool is wider than it first appears. Neurology departments and dedicated epilepsy monitoring units (EMUs) are the largest purchasers of EEG systems, but ICUs increasingly deploy continuous EEG (cEEG) for non-convulsive status epilepticus surveillance, and outpatient sleep labs integrate EEG channels into polysomnography rigs. EMG and nerve conduction study (NCS) systems are workhorses of neurology, physiatry and PM&R, hand surgery, and pain management; the same platforms, expanded to include somatosensory evoked potentials (SSEP), motor evoked potentials (MEP), and brainstem auditory evoked responses (BAER), serve ambulatory surgical centers running intraoperative neuromonitoring (IOM).

What makes this category harder to buy than most diagnostic equipment is the modular, software-defined nature of current systems. A single amplifier chassis sold today might be licensed for routine EEG at purchase and upgraded to LTM, qEEG, or IOM later — or it might not, depending on the vendor's roadmap. Understanding what you're actually buying, and what you're deferring, is the central procurement challenge.

---

Key decision factors

Channel count and study type set the ceiling on clinical utility before anything else. Routine clinical EEG follows the 10-20 electrode system requiring at least 21 channels; pre-surgical seizure localization benefits from 32–64, while source-imaging research or high-density mapping requires 64–256 channels [S7]. For EMG and NCS, 2–4 channels handle the vast majority of clinical studies, but EP and IOM workflows benefit from 8 or more simultaneous acquisition channels. Buying a 21-channel system when your EMU will eventually need 64-channel ictal mapping means a premature capital cycle.

Amplifier specifications are where marketing language diverges most from clinical reality. The numbers that matter: sampling rate of at least 1 kHz per channel for EEG (20–40 kHz per channel for needle EMG to capture fast motor unit potentials), input impedance above 100 MΩ, common-mode rejection ratio (CMRR) exceeding 100 dB, 24-bit A/D resolution, and a noise floor below 1 µV RMS. Ask vendors how these figures degrade when all channels are active simultaneously — a spec quoted at low channel count can look worse at full load.

Modality breadth is a strategic choice, not just a feature comparison. Combined EEG/EMG/EP/IOM platforms reduce footprint, consolidate service contracts, and lower training overhead. The tradeoff is single-vendor dependency; if one modality's software falls behind the market, you're locked into it. High-volume sites with separate neurology and PM&R programs often do better with a dedicated EEG cart plus a separate portable EMG/NCS unit, particularly if case volumes justify dedicated staff and space for each.

Electrode strategy has significant workflow implications that are easy to underestimate during a demo. Wet gel electrodes offer the best long-term impedance stability for multi-day LTM recordings; saline-based systems speed up routine 20-minute outpatient studies; newer dry or soft-tip arrays reduce tech time further but may sacrifice signal quality on patients with thick or oily hair. For EMG, confirm that the stimulator supports constant-current output across a 0–100 mA range, and that disposable monopolar and concentric needle electrodes from third-party suppliers are compatible — proprietary consumable lock-in can add meaningfully to per-study cost over a service life.

Software analytics and AI are increasingly decision-relevant but require scrutiny. Machine learning tools for spike detection, automated seizure identification, and qEEG trending are commercially available and genuinely useful in understaffed settings. However, not all AI features sold by EEG vendors are FDA-cleared as clinical decision support; some are labeled "research use only" [S3, S4]. The distinction matters for liability and accreditation. Request the 510(k) summary for any AI feature and look specifically at the reported false-positive and false-negative rates.

---

What it costs

Pricing in this category spans nearly two orders of magnitude, reflecting the gap between a 2-channel portable EMG unit and a 256-channel networked EMU installation. Published list prices exist for some configurations but many vendors provide quotes only — the figures below represent verified or credibly reported market bands [S8, S11].

• Entry ($8,000–$25,000): Portable 2-channel EMG/NCS units; 21-channel routine EEG carts from second-tier manufacturers; refurbished single-modality systems. Basic used EMG units on the secondary market can trade as low as a few hundred dollars, though buyer liability for condition and software is substantial [S10].
• Mid-range ($25,000–$80,000): Full-featured 32-channel clinical EEG with video sync; combined EMG/NCS/EP platforms at the Cadwell Sierra Summit or Natus Nicolet VikingQuest class. A Brain Products 32-channel research-grade package is reported at approximately $43,000 [S11].
• Premium ($80,000–$175,000+): High-density EEG (64–256 channel), multi-bed EMU video-EEG networks, IOM-capable multi-modal platforms. A complete EGI Geodesic configuration has been reported in the $30,000–$175,000 range depending on electrode array and software tier [S11].

---

Common use cases

The right system spec is inseparable from the study mix. A site doing 10 routine outpatient EEGs per week has different requirements than an academic EMU running continuous 64-channel video-EEG for pre-surgical patients.

• Routine outpatient EEG: 20–40 minute 10-20 montage recordings for epilepsy workup, syncope, or encephalopathy. 21-channel is sufficient; fast electrode application (saline or soft-tip) improves throughput in volume settings.
• Long-term monitoring / EMU: Continuous video-EEG over 24 hours to several days; requires synchronized video, robust storage or cloud streaming, remote neurologist review, and amplifiers rated for extended-wear impedance stability.
• ICU/ED continuous EEG: Bedside cEEG for non-convulsive status epilepticus detection; portable, lightweight amplifiers that connect to existing hospital networks reduce deployment friction in settings where EEG tech availability is already constrained.
• EMG/NCS and IOM: Nerve conduction and needle EMG for neuromuscular diagnosis (ALS, myasthenia gravis, radiculopathy, carpal tunnel); SSEP/MEP/BAER monitoring during spine or cranial surgery requires a multi-modal amplifier with surgeon-facing real-time display.

---

Regulatory and compliance

Clinical EEG amplifiers are FDA Class II devices regulated under 21 CFR 882.1400 (full-montage EEG, product code GWQ) and 21 CFR 882.1835 (physiological signal amplifier, product code GWL); reduced-montage systems use product code OMC [S3, S4]. Diagnostic electromyographs fall under 21 CFR 890.1375, also Class II. Most clearances follow the 510(k) pathway. Verify the 510(k) number against the FDA's public database before purchase — research-grade amplifiers are sometimes marketed in clinical contexts without the required clearance.

The relevant safety standards are IEC 80601-2-26:2019 for electroencephalographs [S1] and IEC 60601-2-40:2016 for electromyographs and evoked response equipment [S2], both riding on the IEC 60601-1 general standard, collateral standard 60601-1-2 (EMC), and 60601-1-6 (usability). EEG applied parts must meet Type CF (cardiac-floating) isolation requirements — the highest patient-protection classification [S1]. For cloud-connected platforms, HIPAA Security Rule obligations apply, and FDA's 2023 premarket cybersecurity guidance (Section 524B) requires a software bill of materials (SBOM); request the manufacturer's MDS2 form as part of due diligence.

---

Service, training, and total cost of ownership

Installation time ranges from a few hours for a plug-in portable EMG unit to one to two weeks for a multi-bed EMU requiring structured cabling, ceiling-mounted cameras, and a centralized review station. Plan technologist training at two to five days for electrode application and system operation; neurologist/reader training is typically one to two days, with additional investment warranted for complex multi-modal platforms. Budget for refresher training when staff turns over — this is a recurring cost that rarely appears in vendor TCO proposals.

Full-service maintenance contracts typically run 8–12% of system list price annually and should include preventive maintenance, software updates, and parts. Watch for vendors who unbundle software upgrades from hardware service — this can materially change the cost trajectory in years three through five. Clinical EEG and EMG amplifiers have an expected useful life of seven to ten years; the PC and headbox components commonly need refresh at five to seven years. The binding constraint is often the OEM's end-of-service announcement rather than hardware failure, so confirm in writing how many years of parts and software support are guaranteed from purchase. Consumables — disposable needle electrodes ($2–$8 each), conductive gel, and abrasive skin prep — are steady recurring costs that a five-year TCO model should include, because consumable spend over a platform's life can approach 40–60% of the original hardware price.

---

Red flags to watch for

A vendor offering a system without a verifiable FDA 510(k) number, or one that describes clearance as "pending," should be treated with skepticism — research-grade devices are not legally marketed for clinical diagnosis [S4]. Refurbished units sold without any remaining warranty or OEM software entitlement shift biomedical liability entirely to the buyer and may be incompatible with current OS versions or EMR interfaces [S10]. Locked proprietary file formats that prevent EDF/EDF+ export are a meaningful operational risk: they complicate second-opinion review, future system migration, and compliance with external audit requests. On EMG systems specifically, slow recovery from stimulator artifact distorts short-latency nerve conduction waveforms — insist on a live demonstration with a challenging NCS case before committing, not just a tabletop review of spec sheets.

---

Questions to ask vendors

1. Provide your FDA 510(k) number(s), product codes, and predicate device(s) for the proposed configuration; supply test reports confirming IEC 60601-1 (3rd ed. + A1), IEC 80601-2-26 (EEG), and/or IEC 60601-2-40 (EMG) compliance.
2. What are the documented per-channel amplifier specs — sampling rate, input impedance, CMRR, A/D resolution, noise floor — and how do these degrade with all channels simultaneously active?
3. Itemize a five-year total cost of ownership: hardware, software licenses (perpetual vs. subscription), service contract tiers, expected consumable spend per study, and PC/OS refresh policy.
4. Which AI or analytic features (seizure detection, qEEG, automated NCS templates) are FDA-cleared as clinical decision support versus labeled research-only, and what are the published false-positive/negative rates from the 510(k) summary?
5. What is your end-of-life policy — specifically, how many years of parts availability and software support are guaranteed from the date of purchase, and what is your published platform sunset process?
6. Provide an MDS2 form and software bill of materials (SBOM); confirm HL7, DICOM Waveform, and EDF/EDF+ export compatibility with our EMR (Epic/Cerner/other), and describe your loaner and mean-time-to-repair guarantee by region.

---

Alternatives

The secondary market for EEG and EMG equipment is deep and reasonably transparent — used single-modality systems regularly trade at 40–60% off list price, and some platforms from established manufacturers remain clinically viable well into their second decade. The tradeoff is real: refurbished units often carry limited or no OEM warranty, may be ineligible for current software versions, and shift biomedical liability to the buyer entirely [S10]. This route suits high-volume practices with in-house biomed capability and existing service relationships.

On the lease-versus-buy question, operating leases (typically three to five years) preserve capital and can bundle service; a fair-market-value lease structure lets you step up at a platform refresh cycle, which in EEG/EMG tends to run every five to seven years. Capital purchase generally wins on a seven-year horizon if utilization is steady and your biomed team can take on hybrid service responsibilities after the initial warranty period. For low-volume outpatient sites, tele-EEG — a cloud-enabled portable headset plus a contracted remote neurophysiologist reader — may be more economical than owning a full cart and employing a dedicated EEG tech, particularly given the documented shortage of credentialed EEG technologists in many U.S. markets.

---

Sources

• IEC 80601-2-26:2019 — Particular requirements for the basic safety and essential performance of electroencephalographs
• IEC 60601-2-40:2016 — Particular requirements for the basic safety and essential performance of electromyographs and evoked response equipment
• 21 CFR Part 882 — Neurological Devices (eCFR)
• FDA 510(k) Summary K170441 — Full-Montage Standard Electroencephalograph
• FDA 510(k) Summary K172312 — eemagine eego EEG amplifiers
• Recommendations for Developing an EEG Laboratory at a Primarily Undergraduate Institution — PMC (NIH)
• Choosing the Right EMG Machine: Cadwell vs. Natus Nicolet/Synergy — MFI Medical
• EMG Unit For Sale or Wanted — DOTmed (used-market pricing reference)
• EEG Machine Price: What to Know Before You Buy — Emotiv